Comparison of Two Postoperative Care Strategies After Breast Surgery
Not yet recruitingNot applicableNCT07880223
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this clinical trial is to compare two postoperative analgesia strategies in adult women undergoing breast surgery and to evaluate their effects on postoperative pain and quality of recovery after hospital discharge. The main questions it aims to answer are: * Does a patient education-based analgesia strategy improve postoperative pain control compared with standard analgesic management? * Does the patient education-based strategy improve quality of recovery after hospital discharge? Researchers will compare the patient education group with the standard care group to assess differences in postoperative pain intensity and quality of recovery. Participants will: * Receive either a patient education-based postoperative analgesia strategy or standard postoperative analgesic management. * Complete questionnaires assessing pain, quality of recovery, and other aspects of health at specified time points. * Be followed for 90 days after surgery.
Study details
- Official title
- The Impact of Patient Education on Postoperative Analgesia Strategy and Its Effect on Pain Intensity and Quality of Recovery After Hospital Discharge: A Pilot Prospective Randomized Controlled Trial
- Conditions
- Interventions
- Behavioral: Patient Education
- Drug: Paracetamol
- Drug: Dexketoprofen
- Drug: Pregabalin
- Drug: Tramadol
- Sponsor
- Moumtzidou Maria Aikaterini
- Organization
- University General Hospital of Heraklion
- Start date
- 2026-10
- Primary completion
- 2027-08
- Sex
- Female
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Greece
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age ≥ 18 years * ASA physical status classification I-III * Provision of written informed consent * Ability to be contacted by telephone Exclusion Criteria: * Hypersensitivity to any of the medications used in the study * Severe hepatic or renal dysfunction * Pregnancy * History of epileptic seizures * Severe psychiatric disorder (e.g., active psychosis or severe depression) affecting their ability to cooperate * Underwent a second surgical procedure before completion of the 3-month follow-up period
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07880223